Sign in Pull a receipt

BIAF

bioAffinity Technologies, Inc.

Healthcare · Diagnostics & Research

$48.00 sample

-0.70 (-1.44%) 1D

Market cap

$244.9B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-13

Alerts

8

Price$48.00 +10.85% 3M daily closessample

48.7041.32

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 27INSInsider sell: Chief Executive Officer
Oct 21INSInsider sell: Director
Oct 13SEC10-Q filed
Oct 05INSInsider sell: EVP, Operations
Sep 29INSInsider sell: Chief Executive Officer
Sep 23SEC8-K filed: material event
Sep 18SECDEF 14A filed
Sep 10INSInsider sell: Chief Financial Officer

Sign up to see the real BIAF record →

Company facts

SEC EDGAR registration

Name: bioAffinity Technologies, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Smart-money score: -59sample, -100 to +100
Reporting currency: USD

Who is positioning in BIAF

sample

Insiders: 11 insider transactions over 90 days, net selling, $747.9M
Congress: 5 members traded over 90 days
Institutions · 13F: 14 funds hold $3.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$12.9B +14.8% y/y

Q4 2024Q3 2026

Inventory$7.2B +2.5% y/y

Q4 2024Q3 2026

Accounts receivable$5.6B +13.1% y/y

Q4 2024Q3 2026

Total debt$14.7B +13.0% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $116.1B -1.1% 3M
Sample peer B: $104.6B -8.8% 3M
Sample peer C: $37.2B +1.3% 3M
Sample peer D: $55.0B +8.0% 3M
Sample peer E: $240.7B -7.7% 3M